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Background: The Notch signaling pathway has been shown to be involved in the development of the nervous
system. Recent studies showed that Notch receptors and ligands are also expressed in the nervous system of adult
animals. However, whether the Notch signaling pathway has a function in adults is not fully understood. The
present study is designed to investigate the function of the Notch signaling pathway in nociceptive transmission,
especially during neuropathic pain in adult rats.
Results: We found that the Notch intracellular domain (NICD) is expressed in the DRG (Dorsal Root Ganglia), sciatic
nerve and spinal cord in normal rats, and is upregulated in the sciatic nerve and spinal cord after spared nerve
injury (SNI). Moreover, we used the γ-secretase (a key enzyme of the Notch signaling pathway) inhibitor DAPT to
observe the effect of the Notch signaling pathway after SNI. We found that intrathecal DAPT significantly increased
paw withdrawal thermal latency and mechanical threshold. Mechanical hyperalgesia occurring after SNI could be
significantly reversed by DAPT in a dose-dependent manner.
Conclusions: These results suggest that the Notch signaling pathway participates in the induction and
maintenance of neuropathic pain, which indicates that the Notch pathway maybe a potential drug target for
neuropathic pain treatment.
Keywords: Neuropathic pain, Notch signaling pathway, DAPTBackground
Chronic pain is a major health problem. Therefore, pro-
viding better treatment and better methods for prevent-
ing chronic pain is of clinical importance. In particular
neuropathic pain, which has a higher morbidity, is se-
verely debilitating, and is largely resistant to treatments.
However, the underlying mechanisms of neuropathic
pain are still unknown. Several mechanisms have been
shown to be involved in the initiation and propagation
of neuropathic pain, including increased excitability and
reduced thresholds of primary sensory neurons, altered
spinal cord synaptic processing, loss of inhibitory inter-
neurons and modifications of brain stem input to the
spinal cord [1-3].* Correspondence: mzkxlz@126.com
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reproduction in any medium, provided the orThe Notch signaling pathway is a highly conserved
pathway in evolution, which is involved in many physio-
logical and pathological processes, such as vasculogenesis,
immunological processes, development, learning and
memory, and tumor formation [4-7]. Notch is one of the
cell-surface receptors that regulate cell-fate decision in the
developing nervous system. Ligands such as Delta and
Jagged bind to Notch receptors, resulting in proteolytic
cleavage of Notch into two sections: an extracellular do-
main and a transmembrane domain. The latter cleavage is
completed by the γ-secretase enzyme and ADAM, result-
ing in the release of a Notch intracellular domain (NICD)
that translocates to the nucleus, where it regulates tran-
scription [8]. Some findings suggest that activation of
Notch signaling can contribute to neuronal death, gener-
ation and activation of microglial cells and astrocytes, in-
hibition of neurite growth [9-11], more dendritic branching
[12], differentiation of oligodendrocyte progenitors and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and the CNS (central nervous system) [14].
Recent studies have demonstrated that activation of
the Notch signaling pathway potentiates synaptic trans-
mission in the hippocampus [15]. The role of the Notch
signaling pathway in sensory sensation, particularly in
nociceptive transmission remains unclear. Therefore, this
study observed the effect of the Notch signaling pathway
on nociceptive responses induced by nerve injury.
Results and discussion
Our present study shows that NICD expression in the rat
sciatic nerve and dorsal horn of the spinal cord is mark-
edly increased following peripheral nerve injury. Seven
days after induction of the unilateral CCI (Sciatic Nerve
Chronic Constriction Injury Model) model, immunoblot
analyses showed that NICD protein levels in the dorsal
horn of the spinal cord increased to ~168.3% of the con-
trol (Figure 1A). NICD protein levels in the sciatic nerve
increased to ~171.4% of the control (Figure 1B), and the
density of the NICD-immunoreactive product in the
spinal cord was increased significantly in laminas I-II at
7 days after nerve injury in the CCI model (Figure 1C).
However, both NICD mRNA and protein levels in rat
DRG neurons were not altered significantly following per-
ipheral nerve injury (Figure 2A-C). Co-immunostaining
of NICD and Substance P, or IB4, indicated that NICDFigure 1 Change in expression of NICD in the sciatic nerve and dorsa
(A) Immunoblotting showed the expression of NICD in the dorsal horn of
(B) Immunoblotting showing the expression of NICD in the sciatic nerve. NICD
showed that the expression of NICD was significantly increased after nerve inpartially co-localized with peptidergic small DRG neurons
(Figure 2D).
To test whether nerve injury-induced NICD expression
contributes to pain hypersensitivity, DAPT, a γ-secretase
enzyme inhibitor, was injected intrathecally (i.t.) before
nerve injury. Spinal NICD expression levels decreased
significantly 7 days after in the SNI model(P< 0.05)
(Figure 3A). We found that DAPT suppressed thermal
hyperalgesia and mechanical allodynia induced by CCI
(Figure 3B) and inhibited the mechanical allodynia
induced by the SNI model in a dose-dependent manner
(Figure 3C). Thus, the marked increase of NICD in the
dorsal spinal cord could be an underlying mechanism for
the development of neuropathic pain.
In this study, we found that NICD was upregulated in
the sciatic nerve and spinal cord after nerve injury.
DAPT, an inhibitor of a key enzyme in the Notch signal-
ing pathway, reversed the thermal hyperalgesia and
mechanical allodynia induced by nerve injury. We there-
fore speculate that the Notch signaling pathway is
involved in the development and maintenance of neuro-
pathic pain.
Recently, a number of studies have shown that
Notch participates in synaptic plasticity, learning and
memory in rodents [16-18], long-term memory forma-
tion in Drosophila [19-21], and locomotive behavior in
C. elegans [22]. Decline of Notch1 expression by 50%l horn of the spinal cord in control and CCI model rats.
the spinal cord. NICD increased after nerve injury (CCI model) (n = 3).
increased after nerve injury (CCI model) (n= 3). (C) Immunostaining
jury (CCI model). Scale bar, 100 μm.
Figure 2 The change in expression of NICD in DRG neurons in control and CCI model rats. (A) Immunostaining showing the expression of
NICD in the DRG. NICD was present in small neurons in the DRG, and nerve injury did not induce significant change. Scale bar, 100 μm.
(B) RT-PCR revealed Notch1 expression in DRG tissue, while nerve injury did not induce a significant change. (C) Immunoblotting showed that in
the rat DRG, the levels of NICD did not markedly change after nerve injury (CCI model) (n= 3). The data represents three independent experiments.
(D) Immunostaining revealed that NICD co-localized with substance P, but did not co-localize with IB4 in the DRG. Scale bar, 100 μm.
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term potentiation (LTP) [18].
In our present study, we demonstrated that NICD is
expressed in the DRG, sciatic nerve and spinal cord in
adult rats, and that NICD was increased in the sciatic
nerve and spinal cord after nerve injury, indicating its
potential role in the development of neuropathic pain.
On the other hand, although the change of NICD ex-
pression in the DRG was not statistically significant
compared with the sciatic nerve and spinal cord, there
was an increasing trend. Our results showed that expres-
sion of NICD in DRG neurons was upregulated from
~53% to ~61%, while western-blot results showed no ap-
parent change in NICD protein levels after nerve injury.
Therefore, we believe that NICD may be transported to
the central terminals after production, so that the ex-
pression of NICD is upregulated in the spinal cord andsciatic nerve. Consistent with our results, some studies
have shown that the Notch signaling pathway enhanced
calcium influx in DRG neurons and also potentiated
synaptic transmission in the hippocampus [15,23]. In
addition, in the spinal cord compression injury model,
the expression of Notch1 increased after spinal cord in-
jury [24]. These results indicated that the Notch signal-
ing pathway is involved in nociceptive transmission in
the spinal cord.Conclusion
In conclusion, activation of the Notch signaling pathway
may contribute to the generation and development of
neuropathic pain. The upregulation of NICD in the
spinal cord after nerve injury is an important factor for
the development of neuropathic pain, and inhibition of
Figure 3 DAPT inhibits thermal hyperalgesia and mechanical allodynia induced by CCI and SNI. (A) Immunostaining revealed that the
increase of NICD expression in the spinal cord after nerve injury was significantly inhibited by injection with DAPT. Scale bar, 100 μm. (B) Intrathecal (i.t.)
administration of DAPT inhibits thermal hyperalgesia and mechanical allodynia 7 days after CCI. (n= 10). (C) Intrathecal (i.t.) DAPT inhibits mechanical
allodynia after SNI in a dose-dependent manner. * P< 0.05, ** P< 0.01, *** P< 0.01 versus SNI rats treated with vehicle (mean± s.e.m., two-way
ANOVA with a post hoc Bonferroni’s test, n = 15).
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Adult male Sprague–Dawley rats (Laboratory Animal
Center of Fourth Military Medical University (FMMU),
China) weighing 180–220 g, were used in the study. The
animals were kept in plastic boxes at 22-26°C with free
access to food and water. All rats were allowed to
acclimatize to the housing facilities and were handled
daily for at least 3 days. All experimental protocols and
animal handling procedures were approved by the
FMMU Animal Care and Use Committee and adhered
to the guidelines for the ethical treatment of animals
established by the International Association for the
Study of Pain.RT-PCR
Notch1 was identified in the rat DRG by RT-PCR
using the following primers: 5’- TGAGATGCTCCCA
GCCAAGT 3’ and 5’- AGATGTATGAAGACTCAAA
GGG -3’(5 min at 95°C, 30s at 95°C, 30s at 58°C, 30s
at 68°C; 40cycle).
Immunoblotting
The DRG, sciatic nerve and spinal cord tissues were
sonicated/homogenized and centrifuged. Thirty micro-
grams of protein was extracted from the above prepara-
tions, and loaded and separated on a 10% (w/v) SDS-
polyacrylamide gel. After transfer, blots were incubated
overnight at 4°C with separately with NICD (1:1000;
Abcam, London, UK) and GAPDH (1:10000; Chemicon,
Temecula, CA, USA) primary antibodies. Blots were
visualized using enhanced chemiluminescence (ECL;
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3 independent experiments. The ECL signal intensity of
NICD versus GADPH was quantified using the NIH
image program.
Immunostaining
Adult male rats were fixed with 4% (w/v) paraformalde-
hyde. For all experimental groups, 12 μm-thick sections
of the fixed L4-5 DRG and L4-5 spinal cord segments
were cut. The sections were processed with indirect im-
munofluorescent histochemistry. Antisera were diluted
in phosphate buffered saline (PBS) containing 0.3% (v/v)
Triton X-100 and 1% (w/v) bovine serum albumin.
Briefly, the sections were incubated with a mixture of
rabbit anti-NICD antibodies (1:500) overnight at 4°C.
The sections were rinsed three times in PBS and then
incubated with fluorescence-conjugated donkey anti–
rabbit (1:100) and rhodamine-conjugated donkey anti-
goat IgG (1:100; Jackson Immuno Research, West Grove,
PA, USA) for 30 min at 37°C. After several rinses in
PBS, the sections were placed under a Leica SP2 confocal
microscope (Leica Microsystem, Heidelberg, Germany)
and images were captured.
SNI model of neuropathic pain
The left SNI model was performed as previously
described [25]. Briefly,Under pentobarbital sodium
anesthesia (40 mg/kg), an incision was made on the left
side skin of the hind leg. The muscle and strands of the
bicep femoris were separated to expose the sciatic
nerve-trunk and carefully separate its three branches:
tibial, common peroneal and sural nerves. After separ-
ation, double ligation of the tibial and common peroneal
was performed using a 5.0 silk thread, and 2–3 mm of
the nerves distal to the ligation were removed, taking
care to avoid inducing any lesion, or stretching the intact
sural nerve. The muscle and skin incisions were then
closed separately. Sham surgery groups only underwent
sciatic nerve-trunk exposure and exposure of their
branches, but did not undergo ligation and transection.
A skin incision was made to blind the observer during
behavioral testing. Animals were habituated to the tester,
the environment, and to the handling procedures before
commencement of testing.
CCI model of neuropathic pain
CCI of the sciatic nerve was used as a model of neuro-
pathic pain, and was adapted to the mouse [26]. Briefly,
under pentobarbital sodium anesthesia (40 mg/kg, intra-
peritoneal injection), the left sciatic nerve was exposed
by blunt dissection around the nerve proximal to the tri-
furcation and loosely ligated at four sites using a 4-0
chromic catgut suture (Jinhuan Medical Instruments
Co., Ltd., Shanghai, China). The distance between thetwo adjacent ligatures was 1 mm. The wound was irri-
gated with saline (0.9% (w/v)) and closed in two layers
with 4-0 silk (facial plane) and surgical skin staples. For
the sham operation, the sciatic nerve was exposed but
not ligated.
Intrathecal surgery and drug injection
The permanent intrathecal catheter (PE-10 polyethylene
tube) was inserted through the gap between the T3 and
T4 vertebrae and extended slowly to the subarachnoid
space of the lumbar enlargement (L4 and L5 segments)
under sodium pentobarbital (40 mg/kg, intraperitoneal
(i.p.) anesthesia. The catheter was filled with sterile NS
(Normal Saline) (approximately 4 μL), and the outer end
was plugged in the skin to avoid the paws. The cannu-
lated rats were allowed to recover for 3-4 days. Exclud-
ing rats with any neurological deficits, at the end of each
experiment, pontamine sky blue was injected via the i.t.
catheter to prove its effectiveness. DAPT (Sigma, St. Louis,
MO, USA), a potent inhibitor of Notch signaling path-
way activation, was freshly dissolved daily in dimethy
sulphoxide (DMSO) to a concentration of 50 mM. Drug
or vehicle (DMSO) was injected over a period of 1 min
via the catheter at a volume of 10 μL, followed by 5 μL
NS for flushing, and all drugs were injected once 30 min
before surgery.
Behavioral testing
Animals were housed in plastic boxes and allowed to
acclimatize for at least 24 h before testing commenced.
This allowed animals to become familiarized with the
handling and environment. Baseline assessments of noci-
ceptive sensitivity were taken for all animals 24 h before
surgery. All behavioral pain tests were conducted at the
same time each day, between 10.00 AM and 1.00 PM.
Thermal hyperalgesia testing
Animals were placed in a clear glass cage with a glass
floor and allowed to acclimatize for 30 min. For the once
pre- and post-drug experiment, a beam of radiant heat
was applied to the middle of the plantar surface of the
operation-lateral paws on days 7, 14, and 21 after drug or
vehicle administration. Withdrawal latency was recorded.
Radiant heat was adjusted so that the baseline latency was
20- 25 s. The cutoff time was 30 s. The latency was exam-
ined at least three times, with at least 10 min between the
two consecutive stimuli on the same paw.
Mechanical allodynia testing
For the once pre- and post-drug experiment, the von
Frey monofilament was conducted on days 7, 14, and 21
after drug or vehicle administration. The degree of
hyperalgesia was expressed as the difference between the
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left paw for each animal.
Data analysis and statistics
All numerical data are presented as the mean±S.E.M.
Statistical significance was determined as P< 0.05 using
the student’s paired t-test and n refers to the number of
neurons studied.
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